INLYTA (Pfizer Laboratories Div Pfizer Inc)
Welcome to the PulseAid listing for the INLYTA drug offered from Pfizer Laboratories Div Pfizer Inc. This Kinase Inhibitor [EPC],Receptor Tyrosine Kinase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Pfizer Laboratories Div Pfizer Inc |
| NON-PROPRIETARY NAME: | axitinib |
| SUBSTANCE NAME: | AXITINIB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Kinase Inhibitor [EPC],Receptor Tyrosine Kinase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-01-27 |
| END MARKETING DATE: | 0000-00-00 |
INLYTA HUMAN PRESCRIPTION DRUG Details:
| Item Description | INLYTA from Pfizer Laboratories Div Pfizer Inc |
| LABELER NAME: | Pfizer Laboratories Div Pfizer Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1(mg/1) |
| START MARKETING DATE: | 2012-01-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0069-0145_7b61175d-743f-4c79-8529-6d1590407e86 |
| PRODUCT NDC: | 0069-0145 |
| APPLICATION NUMBER: | NDA202324 |
Other AXITINIB Pharmaceutical Manufacturers / Labelers:
